PREX2 and neoplasm: Four of the mutations, three truncating variants as well as a point mutant, resulted in a statistically significant decrease in tumor-free survival compared to control melanocytes, expressing wild-type PREX2 (PREX2WT) or green fluorescent protein (GFP).